Improving Health for Patients With Chronic Low Back Pain in Rural Communities Through Telerehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohns Hopkins University

About this trial

Physical therapy is the first line of treatment for patients with low back pain (LBP) and has been shown to be a cost-effective method for improving pain and disability in patients with chronic LBP; however, despite this effectiveness, only 7-13% of patients go on to receive physical therapy services with patients in rural communities being especially limited to do lack of provider availability, transportation, and missed work time leading to greater rates of LBP-related disability and opioid consumption. With the rapid emergence of digital treatment approaches to physical therapy (i.e., telerehabilitation), access could be improved by reducing or eliminating many barriers that patients report; however, it is unclear how to appropriately incorporate digital treatment approaches into existing health care models. The investigators propose a prospective randomized clinical trial conducted at a health system serving rural communities to determine the effectiveness of innovative risk-informed telerehabilitation versus standard educational control for patients with chronic LBP that will match individual patients with specific physical therapy delivery (physical therapy telehealth visits or psychologically informed physical therapy telehealth visits) based on the patient's psychosocial risk of poor outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primary care visit in the past 90 days with an LBP-related International Classification of Diseases (ICD-10) diagnosis.

Age 18 years or older.

At least moderate levels of pain and disability requiring Oswestry score ≥24% and average pain rating ≥ 4/10 points.

Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem? and 2) How often has LBP been an ongoing problem over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.

Disqualifiers

Recent history (last 6 months) of lumbar spine surgery.

Possible non-musculoskeletal cause for low back pain symptoms (e.g., pregnancy).

Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.

Neurological disorder resulting in severe movement disorder, or schizophrenia or other psychotic disorder.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standardized Education

    Behavioral

    Patients randomized to the standardized education group will receive registered access to a study website with access to evidence-based education for patients with chronic LBP. Each participant will have unique login credentials to allow for tracking of individual patient use. The website will include important education on the etiology of chronic LBP and evidence-based suggestions for self-management of symptoms. Education will focus on the importance of maintaining healthy levels of physical activity and avoiding bedrest.

  • Telerehabilitation

    Behavioral

    Based on prior SBTS risk stratification, participants in the risk-informed telerehabilitation group will receive subsequent care using an evidence-based treatment protocol designed for video visits to be informed by a participant's baseline risk score with elements ranging from standard physical therapy telehealth visits (low-to-medium risk) to PIPT telehealth visits (high-risk).

Treatment groups

434 Participants
are divided into 2 treatment groups
Group A: Standardized EducationActive comparator 1 intervention
Group B: TelerehabilitationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Oswestry Disability Index

LBP-related disability. The total score range is \[0, 100\] with higher values representing greater pain-related disability.

Time frame
Change from baseline to 12 weeks after treatment initiation
2

Participants with Opioid Use

self-reported and/or Electronic Health Record (EHR) documented opioid use

Time frame
Post treatment initiation 12 weeks

Secondary outcomes

1

Change in Patient-Reported Outcomes Measurement Information System (PROMIS-29) Physical Function

Physical function. The total score range is \[0, 100\] with higher scores indicating better physical function.

Time frame
Change from baseline to 26- and 52-weeks after treatment initiation
2

Change in Patient-Reported Outcomes Measurement Information System (PROMIS-29) Physical Function by Gender

Physical function. The total score range is \[0, 100\] with higher scores indicating better physical function.

Time frame
Change from baseline to 26- and 52-weeks after treatment initiation
3

Change in Patient-Reported Outcomes Measurement Information System (PROMIS-29) Physical Function by Age Group

Physical function. The total score range is \[0, 100\] with higher scores indicating better physical function.

Time frame
Change from baseline to 26- and 52-weeks after treatment initiation
4

Change in Patient-Reported Outcomes Measurement Information System (PROMIS-29) Physical Function by Baseline Opioid Use

Physical function. The total score range is \[0, 100\] with higher scores indicating better physical function.

Time frame
Change from baseline to 26- and 52-weeks after treatment initiation

Other outcomes

1

Percent of patients approached who accept participation

Implementation - Acceptability as assessed by percent of patients approached who accept participant

Time frame
At Screening
2

Percent of patients offered telerehabilitation

Implementation - Adoption as assessed by percent of patients offered tele-rehabilitation

Time frame
At screening
3

Percent of intervention sessions completed

Implementation - Feasibility as assessed by percent of intervention sessions completed

Time frame
12-weeks after treatment initiation
4

Percent of core treatment components provided during intervention sessions

Implementation - Fidelity as assessed by percent of core treatment components provided during intervention sessions

Time frame
12-weeks after treatment initiation

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Johns Hopkins University

Lead sponsor

TidalHealth, Inc.

Collaborator

Medstar Health Research Institute

Collaborator

Maryland Rural Health Association

Collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator